Dec 11, 2024
17:51

Announcement Pursuant to Rule 13.18 of the Listing Rules

Loan Agreement with Specific Performance Covenant

00882 - TIANJIN DEV

Dec 05, 2024
06:07

Notice of Extraordinary General Meeting

Closure of Books or Change of Book Closure Period

00882 - TIANJIN DEV

Dec 05, 2024
06:06

Form of Proxy for Extraordinary General Meeting to be held on 30 December 2024

Proxy Forms

00882 - TIANJIN DEV

Dec 05, 2024
06:04

Renewal of Existing Continuing Connected Transactions with Tianjin TEDA Investment Holding Co., Ltd. and Notice of Extraordinary General Meeting

Documents on Display

00882 - TIANJIN DEV

Nov 26, 2024
06:03

An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Overseas Regulatory Announcement - Other

00882 - TIANJIN DEV

Nov 15, 2024
18:11

Renewal of Existing Continuing Connected Transactions and Entering Into of New Continuing Connected Transactions with Tianjin TEDA Investment Holding Co., Ltd.

Continuing Connected Transaction

00882 - TIANJIN DEV

Nov 15, 2024
17:48

Renewal of Existing Continuing Connected Transactions with Tianjin Pharmaceutical Group Co., Ltd.

Continuing Connected Transaction

00882 - TIANJIN DEV

Oct 30, 2024
06:02

Unaudited Financial Results for the nine months ended 30 September 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.

Results of a Subsidiary

00882 - TIANJIN DEV